/

Empresas

Ab

No verificado

AbbVie

Sobre qué escribimos

AgriculturaFitnessMedicina - VariosMedio Ambiente/EcologíaSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa

06/07/2026

Salud

Fitness

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

Fuente

Editor

1.00

0

29/06/2026

Salud

Fitness

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Fuente

Editor

1.00

0

29/06/2026

Salud

Fitness

Medicina - Varios

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Fuente

Editor

1.00

0

29/06/2026

Salud

Fitness

Medicina - Varios

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

Fuente

Editor

1.00

0

23/06/2026

Salud

Fitness

Medicina - Varios

Ciencia

Medio Ambiente/Ecología

Agricultura

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

Fuente

Editor

1.00

0

22/06/2026

Salud

Fitness

Empresas

Industria

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

Fuente

Editor

1.00

0

12/06/2026

Salud

Fitness

Ferias y Congresos

Eventos

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results

Fuente

Editor

1.00

0

08/06/2026

Salud

Fitness

Ferias y Congresos

Eventos

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

Fuente

Editor

1.00

0

02/06/2026

Salud

Fitness

Medicina - Varios

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Fuente

Editor

1.00

0

29/05/2026

Salud

Fitness

Administración pública

Medicina - Varios

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0